ChronoScale Corporation Common Stock (NASDAQ:CHRN – Get Free Report) shares rose 6.6% during trading on Wednesday . The company traded as high as $18.87 and last traded at $18.83. Approximately 39,104 shares were traded during trading, a decline of 84% from the average session volume of 243,492 shares. The stock had previously closed at $17.66.
Wall Street Analyst Weigh In
Separately, Weiss Ratings upgraded shares of ChronoScale Corporation Common Stock from a “sell (d-)” rating to a “sell (d)” rating in a research report on Monday, August 24th. One equities research analyst has rated the stock with a Hold rating and one has assigned a Sell rating to the stock. According to MarketBeat.com, the stock presently has a consensus rating of “Reduce” and an average target price of $6.00.
View Our Latest Report on CHRN
ChronoScale Corporation Common Stock Stock Performance
ChronoScale Corporation Common Stock (NASDAQ:CHRN – Get Free Report) last posted its earnings results on Wednesday, August 19th. The company reported ($0.12) earnings per share for the quarter. ChronoScale Corporation Common Stock had a negative net margin of 135.66% and a negative return on equity of 197.81%. The company had revenue of $18.40 million for the quarter. Sell-side analysts anticipate that ChronoScale Corporation Common Stock will post -0.1 earnings per share for the current fiscal year.
Institutional Investors Weigh In On ChronoScale Corporation Common Stock
A number of large investors have recently added to or reduced their stakes in the stock. Roble Belko & Company Inc grew its holdings in ChronoScale Corporation Common Stock by 104.5% during the first quarter. Roble Belko & Company Inc now owns 2,338 shares of the company’s stock valued at $25,000 after purchasing an additional 1,195 shares during the last quarter. Virtu Financial LLC acquired a new stake in shares of ChronoScale Corporation Common Stock in the third quarter worth $57,000. Shay Capital LLC bought a new stake in shares of ChronoScale Corporation Common Stock during the 3rd quarter worth $67,000. Geode Capital Management LLC grew its stake in ChronoScale Corporation Common Stock by 68.9% in the 4th quarter. Geode Capital Management LLC now owns 25,212 shares of the company’s stock valued at $218,000 after buying an additional 10,281 shares during the last quarter. Finally, Citadel Advisors LLC acquired a new position in ChronoScale Corporation Common Stock during the 3rd quarter worth $198,000. Institutional investors own 6.42% of the company’s stock.
ChronoScale Corporation Common Stock Company Profile
Ekso Bionics Holdings, Inc (NASDAQ:EKSO) is a leading developer of wearable bionic exoskeletons designed to enhance human mobility and strength. Headquartered in Richmond, California, the company was founded in 2005 (originally as Berkeley Bionics) and completed its initial public offering in 2014. Its patented robotic systems support both rehabilitation and industrial applications by providing powered, adjustable assistance for a range of movement tasks.
In the medical sector, Ekso Bionics offers externally worn exoskeletons such as the EksoNR and EksoGT, which assist patients recovering from stroke, spinal cord injury or other neurological conditions.
Read More
- Five stocks we like better than ChronoScale Corporation Common Stock
- GitLab’s Earnings Beat Just Gave Software Bulls a New SaaSpocalypse Test
- Strategic Strike: Strategy Deploys $370M to Fortify Bitcoin
- Lilly’s Merida Deal Shows the GLP-1 King Is Already Thinking Beyond Obesity
- From High Dividend Growth to High Yield, These 3 Stocks Just Boosted Dividend Payouts
Receive News & Ratings for ChronoScale Corporation Common Stock Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ChronoScale Corporation Common Stock and related companies with MarketBeat.com's FREE daily email newsletter.
